• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
First report of an extensively drug-resistant VIM-2 metallo-β-lactamase-producing Brevundimonas diminuta clinical isolate.首例广泛耐药 VIM-2 型金属β-内酰胺酶产生短小芽胞杆菌临床分离株报告。
J Clin Microbiol. 2012 Aug;50(8):2830-2. doi: 10.1128/JCM.00924-12. Epub 2012 Jun 12.
2
Brevundimonas diminuta bacteremia in a man with myelodysplastic syndromes.一名患有骨髓增生异常综合征的男性发生浅黄短杆菌菌血症。
Indian J Pathol Microbiol. 2015 Jul-Sep;58(3):384-6. doi: 10.4103/0377-4929.162920.
3
Bacteremia caused by Brevundimonas species at a tertiary care hospital in Taiwan, 2000-2010.2000-2010 年台湾一家三级保健医院由脆弱拟杆菌引起的菌血症。
Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1185-91. doi: 10.1007/s10096-011-1210-5. Epub 2011 Apr 3.
4
Emergence of VIM-6 metallo-beta-lactamase-producing Alcaligenes faecalis clinical isolates in a hospital in India.印度一家医院中出现产VIM-6金属β-内酰胺酶的粪产碱杆菌临床分离株。
J Infect Dev Ctries. 2013 Jun 15;7(6):494-6. doi: 10.3855/jidc.3556.
5
Molecular characterization of IMP-type metallo-β-lactamases among multidrug-resistant Achromobacter xylosoxidans.耐多药木糖氧化无色杆菌中 IMP 型金属β-内酰胺酶的分子特征。
J Antimicrob Chemother. 2012 Sep;67(9):2110-3. doi: 10.1093/jac/dks179. Epub 2012 May 10.
6
First identification of an Escherichia coli clinical isolate producing both metallo-beta-lactamase VIM-2 and extended-spectrum beta-lactamase IBC-1.首次鉴定出一株同时产生金属β-内酰胺酶VIM-2和超广谱β-内酰胺酶IBC-1的大肠埃希菌临床分离株。
Clin Microbiol Infect. 2004 Aug;10(8):757-60. doi: 10.1111/j.1469-0691.2004.00913.x.
7
Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases.OP0595与β-内酰胺类药物联合对产超广谱β-内酰胺酶、AmpC酶和碳青霉烯水解β-内酰胺酶的革兰氏阴性菌的活性。
J Antimicrob Chemother. 2015 Nov;70(11):3032-41. doi: 10.1093/jac/dkv239. Epub 2015 Aug 25.
8
Selective enumeration strategies for Brevundimonas diminuta from drinking water.从饮用水中选择性枚举寡养单胞菌的策略。
J Ind Microbiol Biotechnol. 2010 Apr;37(4):407-17. doi: 10.1007/s10295-010-0689-6. Epub 2010 Jan 20.
9
Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital.产 VIM-4 奇异变形杆菌引起的克隆爆发在一家希腊三级保健医院。
Int J Antimicrob Agents. 2020 Aug;56(2):106060. doi: 10.1016/j.ijantimicag.2020.106060. Epub 2020 Jun 20.
10
Metallo-beta-lactamases: the quiet before the storm?金属β-内酰胺酶：暴风雨前的宁静？
Clin Microbiol Rev. 2005 Apr;18(2):306-25. doi: 10.1128/CMR.18.2.306-325.2005.

引用本文的文献

1
Resveratrol Alleviated Intensive Exercise-Induced Fatigue Involving in Inhibiting Gut Inflammation and Regulating Gut Microbiota.白藜芦醇通过抑制肠道炎症和调节肠道微生物群减轻高强度运动诱导的疲劳。
Food Sci Nutr. 2025 May 23;13(6):e70304. doi: 10.1002/fsn3.70304. eCollection 2025 Jun.
2
Yearlong analysis of bacterial diversity in hospital sink drains: culturomics, antibiotic resistance and implications for infection control.医院水槽排水管道细菌多样性的长期分析：培养组学、抗生素耐药性及对感染控制的影响
Front Microbiol. 2025 Feb 14;15:1501170. doi: 10.3389/fmicb.2024.1501170. eCollection 2024.
3
Brevundimonas diminuta Bacteremia in a Case of Adrenal Insufficiency: A Case Report and Literature Review.肾上腺功能不全患者的缺陷短波单胞菌菌血症：病例报告及文献综述
Cureus. 2024 Dec 18;16(12):e75943. doi: 10.7759/cureus.75943. eCollection 2024 Dec.
4
spp. infection in immunocompromised children: Two case reports.免疫功能低下儿童的 spp. 感染：两例病例报告。
Germs. 2023 Mar 31;13(1):72-79. doi: 10.18683/germs.2023.1369. eCollection 2023 Mar.
5
Comparisons of the Oral Microbiota from Seven Species of Wild Venomous Snakes in Taiwan Using the High-Throughput Amplicon Sequencing of the Full-Length 16S rRNA Gene.利用全长16S rRNA基因的高通量扩增子测序对台湾七种野生毒蛇口腔微生物群进行比较
Biology (Basel). 2023 Sep 4;12(9):1206. doi: 10.3390/biology12091206.
6
Brevundimonas diminuta-Induced Lung Abscess in an Immunocompetent Adult: A Rare Case Report.免疫功能正常的成年人中由缺陷短波单胞菌引起的肺脓肿：1例罕见病例报告
Cureus. 2023 Jul 24;15(7):e42371. doi: 10.7759/cureus.42371. eCollection 2023 Jul.
7
sp. nov.: a New Multidrug-Resistant Species Isolated from a Patient in Brazil.sp. nov.：从巴西的一位患者身上分离出的一种新的多药耐药物种。
Microbiol Spectr. 2023 Jun 15;11(3):e0441522. doi: 10.1128/spectrum.04415-22. Epub 2023 Apr 17.
8
First Isolation and Clinical Case of in a Newborn with Low Birth Weight, in Democratic Republic of Congo: A Case Report.首例在刚果民主共和国低出生体重儿中分离出的 ：病例报告。
Medicina (Kaunas). 2021 Nov 11;57(11):1227. doi: 10.3390/medicina57111227.
9
Carbapenem Resistance among Marine Bacteria-An Emerging Threat to the Global Health Sector.海洋细菌中的碳青霉烯类耐药性——对全球卫生部门的新威胁
Microorganisms. 2021 Oct 14;9(10):2147. doi: 10.3390/microorganisms9102147.
10
Coming from the Wild: Multidrug Resistant Opportunistic Pathogens Presenting a Primary, Not Human-Linked, Environmental Habitat.源自野外：呈现原发性而非人类相关环境栖息地的多药耐药机会性病原体。
Int J Mol Sci. 2021 Jul 28;22(15):8080. doi: 10.3390/ijms22158080.

本文引用的文献

1
Environmental microbiota represents a natural reservoir for dissemination of clinically relevant metallo-beta-lactamases.环境微生物菌群是临床相关金属β-内酰胺酶传播的天然储库。
Antimicrob Agents Chemother. 2011 Nov;55(11):5376-9. doi: 10.1128/AAC.00716-11. Epub 2011 Aug 22.
2
Brevundimonas diminuta keratitis.微小棒状杆菌角膜炎。
Eye Contact Lens. 2012 Jan;38(1):63-5. doi: 10.1097/ICL.0b013e31821c04f7.
3
First case of human infection due to Pseudomonas fulva, an environmental bacterium isolated from cerebrospinal fluid.首例人类感染铜绿假单胞菌病例，该细菌是从脑脊液中分离出来的环境细菌。
J Clin Microbiol. 2010 Feb;48(2):660-4. doi: 10.1128/JCM.01849-09. Epub 2009 Dec 23.
4
First isolation of two colistin-resistant emerging pathogens, Brevundimonas diminuta and Ochrobactrum anthropi, in a woman with cystic fibrosis: a case report.首次在一名囊性纤维化女性患者中分离出两种耐黏菌素的新出现病原体——缺陷短波单胞菌和嗜人苍白杆菌：病例报告
J Med Case Rep. 2008 Dec 5;2:373. doi: 10.1186/1752-1947-2-373.
5
VIM-2-producing Pseudomonas putida, Buenos Aires.产VIM-2的恶臭假单胞菌，布宜诺斯艾利斯
Emerg Infect Dis. 2007 Apr;13(4):668-9. doi: 10.3201/eid1304.061083.
6
Chemical resistance of the gram-negative bacteria to different sanitizers in a water purification system.革兰氏阴性菌对水净化系统中不同消毒剂的耐药性。
BMC Infect Dis. 2006 Aug 16;6:131. doi: 10.1186/1471-2334-6-131.
7
Brevundimonas diminuta infections and its resistance to fluoroquinolones.缺陷短波单胞菌感染及其对氟喹诺酮类药物的耐药性。
J Antimicrob Chemother. 2005 Jun;55(6):853-9. doi: 10.1093/jac/dki139. Epub 2005 May 9.
8
First isolation of blaVIM-2 in an environmental isolate of Pseudomonas pseudoalcaligenes.首次在假产碱假单胞菌的环境分离株中分离出blaVIM-2。
Antimicrob Agents Chemother. 2005 May;49(5):2140-1. doi: 10.1128/AAC.49.5.2140-2141.2005.
9
Metallo-beta-lactamases: the quiet before the storm?金属β-内酰胺酶：暴风雨前的宁静？
Clin Microbiol Rev. 2005 Apr;18(2):306-25. doi: 10.1128/CMR.18.2.306-325.2005.
10
Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp.评估 Hodge 试验和亚胺培南 - EDTA 双纸片协同试验用于鉴别产金属β-内酰胺酶的假单胞菌属和不动杆菌属菌株
J Clin Microbiol. 2003 Oct;41(10):4623-9. doi: 10.1128/JCM.41.10.4623-4629.2003.

首例广泛耐药 VIM-2 型金属β-内酰胺酶产生短小芽胞杆菌临床分离株报告。

First report of an extensively drug-resistant VIM-2 metallo-β-lactamase-producing Brevundimonas diminuta clinical isolate.

机构信息

Laboratorio de Bacteriología, Instituto de Fisiopatología y Bioquímica Clínica, Hospital de Clínicas José de San Martín, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.

出版信息

J Clin Microbiol. 2012 Aug;50(8):2830-2. doi: 10.1128/JCM.00924-12. Epub 2012 Jun 12.

DOI:10.1128/JCM.00924-12
PMID:22692741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3421493/
Abstract

In the literature, only three Brevundimonas diminuta environmental isolates carrying metallo-β-lactamase genes were recently published. However, so far, no B. diminuta clinical isolates carrying these carbapenem resistance genes have been described. Here we report the first VIM-2 metallo-β-lactamase-producing B. diminuta clinical isolate obtained from an immunocompromised patient.

摘要

在文献中，最近仅发表了三篇携带金属β-内酰胺酶基因的卑弥呼短杆菌环境分离株。然而，迄今为止，尚未描述过携带这些碳青霉烯类耐药基因的卑弥呼短杆菌临床分离株。在此，我们报道了首例从免疫功能低下患者中分离出的产 VIM-2 金属β-内酰胺酶的卑弥呼短杆菌临床分离株。